WinstonWınston
Back
Chemed Corporation logo

Chemed Corporation

CHE
58
Medical - Care Facilities · Healthcare
Price
$540.57
+5.69 (+1.06%)
Market Cap
$7.07B
Winston Score
58
Winston is curious
A decent business — some strong pillars, some weaker.
Data as of Aug 23, 2026 · filings through Jun 30, 2026
How the score breaks down
Quality
Good
Growth
Mixed
Cash Flow
Exceptional
Stability
Exceptional
Valuation
Good
Dividends
Good

Share count falling — buybacks

9.7% over 4y

The company has reduced its share count over this period, returning value to shareholders through buybacks.

Diluted shares outstanding: 15.9M (2021) → 14.4M (2025)

Winston Score History

The full picture

Chemed Corporation runs two very different businesses under one roof. The first is VITAS Healthcare, one of the largest hospice care providers in the United States, which helps terminally ill patients and their families during end-of-life care. The second is Roto-Rooter, a well-known plumbing and drain-cleaning service that works with both homeowners and businesses across North America.

Chemed makes money by billing Medicare and Medicaid for most of its hospice services, while Roto-Rooter earns revenue through one-time service calls and recurring plumbing contracts. The company operates almost entirely in the United States and generates roughly $2 billion in annual revenue. Its competitive edge comes from Roto-Rooter's strong brand recognition and VITAS's large, established network of hospice locations, which are difficult and expensive to replicate. The key risk is that VITAS depends heavily on government reimbursement rates, meaning any cuts to Medicare hospice payments could directly hurt profits.

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+8.8% YoY

YoY Growth Rate

Slow revenue growth

EPS Growth

+42.5% YoY

YoY Growth Rate

EPS growth accelerating

R&D Spend

$0/ year

0.0% of revenue

Below sector average (18%)

Research and development spending

Insider Activity

1.8%ownership

Flat

Insider ownership roughly steady over the past year

Cash Position

Cash flow positive

$188M cash & investments

Quarterly Free Cash Flow

↑ Burn rate improving

Company generates more cash than it spends — no dilution risk from fundraising

Growth context

Chemed Corporation is growing revenue at 9% year-over-year. The Winston Score measures business quality today — these growth metrics show what could matter tomorrow.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale
Gross Margin
30.4%
Modest — 30.4% gross margin
Profit after running costs
Operating Margin
13.2%
Healthy — 13.2% operating margin
Return on the money invested
ROCE
34.5%
Exceptional — 34.5% return on capital

ROIC above 25%. Every dollar invested in the business earns more than 25 cents back per year.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth
Sales YoY
+3.3%
Slow sales growth (+3.3% YoY)
Profit growth
EPS YoY
+1.5%
Flat earnings

Single-digit earnings growth — steady but not exciting.

How steady the profit is
EPS Consistency
4/8 quarters
Earnings inconsistent quarter-to-quarter

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash
Cash Conversion
142%
Turns 142% of profit into real cash
Spare cash per sale
FCF Margin
12.5%
Converts sales into free cash efficiently (12.5%)

FCF margin between 10% and 20%. Every $100 in sales becomes $10 to $20 in real cash.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns
Debt / Equity
0.22
Conservative — low debt load (0.22)
Covers its interest
Interest Cover
72.40x
Comfortably covers interest (72.4x)

Interest coverage above 8. Profits cover interest many times over.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit
P/E Ratio (TTM)
27.1x
Growth-priced — P/E 27.1

P/E above the market average. People are paying up for expected growth.

Cheaper or dearer next year
P/E vs Forward
+5.4
GROWING
Earnings expected to grow meaningfully — cheaper on forward P/E (27.1 → 21.8)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Dividend
Dividend Yield
0.52%
Small dividend — 0.52% yield

Modest yield. The bulk of any return needs to come from price appreciation.

Dividend record
Dividend Growth
+19.0%
Dividend growing fast (19.0% YoY)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial